-
On Thursday, Gov. Ron DeSantis included $15 million in his proposed 2021-22 budget for an importation program. That would come on top of $10 million the Legislature already directed toward the plan.
-
The pandemic was the dominant — but not the only — health policy story of 2020. In this Kaiser Health News podcast, panelists look at some of the year's biggest non-coronavirus stories.
-
The controversial deal hashed out between the Department of Justice and the maker of Oxycontin provides hundreds of millions of dollars of relief for communities hit hard by the opioid epidemic.
-
China banned fentanyl last year, but an NPR investigation reveals how Chinese vendors continue to market the chemicals used to make the drug on e-commerce and social media sites.
-
The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.
-
Florida’s plan to import cheaper prescription drugs from Canada — designed by Gov. Ron DeSantis and endorsed by President Donald Trump — has tasted its…
-
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
-
Don’t worry. Future COVID-19 vaccinations will be affordable and available. That was the message that Lori M. Reilly, chief operating officer of the…
-
California will be the first state to create its own line of generic drugs to cope with high drug prices. A new law lets the state outsource manufacturing but control pricing and distribution.
-
Over the objections of drugmakers, the Trump administration is expected within weeks to finalize its plan that would allow states to import some…